u/kofi_balogun
Contributes reviews on supplier material. Based in Lagos.
member · joined 13 Apr 2025
Comments — page 2 of 4
comment on [Lab] SSA reta — Medutest came back 97.4% against a claimed 96.2% in c/retatrutide · 5 points · 4 months ago
phase 2 numbers are not maintenance numbers, cite the trial
comment on [Lab] SSA reta — Medutest came back 97.4% against a claimed 96.2% in c/retatrutide · 1 points · 4 months ago
Strongly agree. Heart rate escalation needs the actual data, not impressions.
comment on ALT: what the trials say vs what this community says in c/bloodwork · 22 points · 4 months ago
This is correct. ApoB is the better marker.
comment on [Meta] proposal — a flair for SURMOUNT posts in c/tirzepatide · 13 points · 6 months ago
SURMOUNT data is messier than STEP data but the weight loss is there
comment on reading retatrutide threads from 2024 and half of it aged badly in c/retatrutide · -23 points · 7 months ago
Crossposting this to c/sideeffects because the people who need it are not reading this community.
comment on anyone else notice ferritin kicking in around week 84 in c/bloodwork · 22 points · 8 months ago
ApoB from 7 to 34 is movement, not noise
comment on anyone else notice ferritin kicking in around week 84 in c/bloodwork · 67 points · 8 months ago
comment on retatrutide vs triple agonist — genuinely asking which matters more in c/retatrutide · 219 points · 8 months ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on switched from 2.5mg to 2.4mg and the sulphur burps got better, not worse in c/retatrutide · 57 points · 9 months ago
Mechanistically the bit that matters is triple agonist. It explains most of the early profile and a decent chunk of the outcome.
comment on switched from 12.5mg to 10mg and the nausea got better, not worse in c/tirzepatide · 33 points · 10 months ago
Cosigning. The GIP contribution is real and the side effects are not simply scaled versions.
comment on [Question] how do you actually verify SURPASS in c/tirzepatide · 188 points · 11 months ago
Not convinced. The evidence does not support that reading.
comment on unpopular opinion: 15mg is massively overrated in c/tirzepatide · 76 points · 1 year ago
This matches the trial data. SURMOUNT-1 was 94.2% body weight at 4 weeks.
comment on stalled for 18 weeks at 2.4mg and I refuse to panic this time in c/retatrutide · 436 points · 1 year ago
The heart rate signal in TRIUMPH is real and concerning. Higher doses had higher mean HR changes.
comment on [Question] how do you actually verify ALT in c/bloodwork · 30 points · 1 year ago
Strongly agree. ALT is where you catch the liver story early.
comment on [Question] Mounjaro — what am I missing here in c/tirzepatide · 78 points · 1 year ago
Is that on Mounjaro pens or research tirzepatide?
comment on tried phase 2 for 12 weeks. here is what happened. in c/retatrutide · 19 points · 1 year ago
Disagree but this is the good kind of wrong — it is specific enough to be checked.
comment on my ApoB moved and I cannot work out whether tirzepatide is why in c/tirzepatide · 875 points · 1 year ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on anyone else notice retatrutide kicking in around week 49 in c/retatrutide · 1 points · 1 year ago
the weight curves are unusually steep, which makes predicting individual response harder
comment on my A1c moved and I cannot work out whether phase 2 is why in c/retatrutide · 16 points · 1 year ago
the dosing is steep, the sulphur burps reports are real, and nobody knows the human safety yet
comment on [Discussion] can we stop arguing about Zepbound until somebody posts a number in c/tirzepatide · -5 points · 1 year ago
Cosigning. The GIP contribution is real and the side effects are not simply scaled versions.